Search results for:
DOXOrubicin liposomal
DOXOrubicin liposomal
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| DOXOrubicin Liposomal |
DISPERSION, INTRAVENOUS |
2 mg/mL (10 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DOXOrubicin Liposomal |
DISPERSION, INTRAVENOUS |
2 mg/mL (25 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Jun. 18, 2024
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions